trending Market Intelligence /marketintelligence/en/news-insights/trending/FD8JBoQw-atVD6EtQ4221Q2 content esgSubNav
In This List

Protagonist Therapeutics appoints director

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Protagonist Therapeutics appoints director

Protagonist Therapeutics, Inc. appointed Sarah Noonberg to the board, replacing Julie Grant.

Noonberg is the chief medical officer of Prothena Corp. plc. Grant, who has stepped down from the board, is a partner at Canaan Partners.